Business
Re Agreement
Re Agreement.
About this update from Aura Renewable Acquisitions Plc
[{"type":"text","content":"\n Ardana PLC\n13 February 2007\n\n ARDANA SIGNS AGREEMENT WITH\n\n TWINPHARMA TO MARKET STRIANTTM SR\n\n IN THE NETHERLANDS\n\n\n\nEdinburgh, UK, 13 February 2007: Ardana plc (LSE:ARA) today announces that it\nhas signed an agreement granting TwinPharma BV ('TwinPharma') exclusive rights\nto market StriantTM SR in the Netherlands.\n\n\n\nStriantTM SR is a mucoadhesive buccal (gum surface) testosterone replacement\ntherapy for confirmed male hypogonadism (i.e. those suffering from a deficiency\nor absence of testosterone). StriantTM SR is the first-to-market buccal adhesive\ntablet and is marketed to urologists and endocrinologists by Ardana's own sales\nforce in the UK, and via partners in Germany, Ireland and the Nordic Region.\n\n\n\nTwinPharma will shortly launch StriantTM SR in the Netherlands as pricing and\nreimbursement has now been agreed with the Netherlands Health Authority.\n\n\n\nDr. Maureen Lindsay, Chief Executive of Ardana, said: 'Today's announcement\nshows Ardana's continued commitment to expand its product portfolio into the\nEuropean market with specialist collaborations in each country. We are very\npleased to be working with TwinPharma to ensure that we continue to introduce\nnovel therapies for indications where there are unmet patient needs.'\n\n\n\nGert van Alewijk and Bauke Buwalda, founders of TwinPharma, said: 'We set up\nTwinPharma with the ambition to introduce novel medicines into the Dutch market.\nStriantTM SR is a truly novel therapy and fits perfectly with the strategic view\nof TwinPharma. The collaboration with Ardana Bioscience is very professional and\ninspiring and we are looking forward to a successful and pleasant cooperation.'\n\n\n\n\n\nFor more information contact:\nArdana Financial Dynamics\nMaureen Lindsay (corporate/financial media relations)\nTel: + 44 (0) 131 226 8550 Julia Phillips/John Gilbert\n Tel: +44 (0)20 7831 3113\nTwinPharma\nBauke Buwalda\nTel: + 31 (0) 348 493015\n\n\n\n\n\nAbout Ardana\n\nArdana plc is a pharmaceutical company focused on the discovery, development and\nmarketing of innovative products to improve human reproductive health, a $25.5\nbillion market.\n\n\n\nSince its foundation, Ardana has built a broad and balanced portfolio to manage\nrisk and actively pursues product and technology in-licensing and outlicensing\nto maintain a robust pipeline.\n\n\n\nAr...